🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the effects of daily consumption of 3 capsules of Swisse Nutra+...
Status
Completed
Location
CSIRO Nutrition and Health Research Clinic
Start Date
2021-04-30
Trial ID
NCT04783714
Treatments Being Tested
The purpose of this placebo-controlled trial is to compare the effects of 2...
Status
Recruiting
Location
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
Start Date
2024-09-15
Trial ID
NCT06933095
The study is a randomized, placebo-controlled, triple-blind, parallel group...
Status
Recruiting
Location
KGK Science Inc.
Start Date
2025-12-06
Trial ID
NCT07034794
CADASIL is a paradigmatic cerebral small vessel disease responsible for whi...
Status
Completed
Location
Hôpital Lariboisière APHP
Start Date
2020-12-21
Trial ID
NCT04658823
Treatments Being Tested
A randomized, double-blind, placebo-controlled, parallel group study to com...
Status
Completed
Location
RDC Clinical Pty Ltd
Start Date
2024-06-21
Trial ID
NCT06266000
The purpose of this study is to determine the effects of a palm-oil derived...
Status
Withdrawn
Location
UCLA Center for Human Nutrition, 900 Veteran Avenue, WH 14-187
Start Date
2013-10-30
Trial ID
NCT02142569
Daily intake of Nigella sativa for 12 weeks is effective in the treatment o...
Status
Completed
Location
Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University
Start Date
2013-01
Trial ID
NCT01735097
Treatments Being Tested
Rationale: Cis-9, trans-11 conjugated linoleic acid (CLA) can protect again...
Status
Completed
Location
Julius Center for Health Sciences and Primary Care, UMC Utrecht
Start Date
2007-06
Trial ID
NCT00706745
Treatments Being Tested
This study is designed to evaluate the effectiveness of a proprietary nutri...
Status
Completed
Location
1621 Bridgeway
Start Date
2010-10-08
Trial ID
NCT03209895
Treatments Being Tested